Followers | 81 |
Posts | 16087 |
Boards Moderated | 2 |
Alias Born | 12/02/2007 |
Monday, April 27, 2015 6:45:27 PM
First- I would sever all business relationships which are also familial relationships of the former CEO.
Mixing business and family only serves to raise the specter of impropriety.
Mixing a publicly traded company's finances with the family of the former CEO is IMO a highly questionable form of management. Why not err on the side of caution and mange above suspicion?
Second- I would sever all ties with any and all employees, service providers, divers, boat operators, and volunteers who post on any public forum the activity of the company without the express written direction of the company. I don't think that's beyond anybody's comprehension, n'est-ce pas?
Third - I wouldn't utter a word to the public beyond that which is mandatory. If investors can't stand the silence, they are free to seek investment opportunities elsewhere.
Recent SFRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:22:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:21:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:20:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:18:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 07:28:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 08:54:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:27:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:43:48 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 08/04/2023 08:34:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM